The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Human papillomavirus oncoproteins: pathways to transformation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“The HPV E7 protein binds to Rb family members and targets them for degradatio”
BackgroundKiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“E6 mutants deficient for degradation of p53 can still immortalize cell”
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
DNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784
Cited by
Integrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
Exploiting the curative potential of adoptive T‐cell therapy for cancer
Hinrichs, C. S., & Rosenberg, S. A. (2014) · Immunological Reviews · doi:10.1111/imr.12132 · Cited by 466
CHK2 kinase in the DNA damage response and beyond
Zannini, L., Delia, D., & Buscemi, G. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju045 · Cited by 455
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Leko, V., & Rosenberg, S. A. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.013 · Cited by 449
The causes and consequences of polyploidy in normal development and cancer
Davoli, T., & de Lange, T. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154234 · Cited by 424
Iglesias-Bartolome, R., Patel, V., Cotrim, A., Leelahavanichkul, K., Molinolo, A. A., Mitchell, J. B., & Gutkind, J. S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.06.007 · Cited by 284
Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus
Zhao, J., Lee, E. E., Kim, J., Yang, R., Chamseddin, B., Ni, C., Gusho, E., Xie, Y., Chiang, C.-M., Buszczak, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10246-5 · Cited by 276
Self-citationZhang, L., Wu, J., Ling, M. T., Zhao, L., & Zhao, K.-N. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0361-x · Cited by 264
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Polyploidy in liver development, homeostasis and disease
Donne, R., Saroul-Aïnama, M., Cordier, P., Celton-Morizur, S., & Desdouets, C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0284-x · Cited by 188
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Long-term culture and expansion of primary human hepatocytes
Levy, G., Bomze, D., Heinz, S., Ramachandran, S. D., Noerenberg, A., Cohen, M., Shibolet, O., Sklan, E., Braspenning, J., & Nahmias, Y. (2015) · Nature Biotechnology · doi:10.1038/nbt.3377 · Cited by 155
Chiang, C., Pauli, E.-K., Biryukov, J., Feister, K. F., Meng, M., White, E. A., Münger, K., Howley, P. M., Meyers, C., & Gack, M. U. (2018) · Journal of Virology · doi:10.1128/jvi.01737-17 · Cited by 140
Banerjee, N. S., Wang, H.-K., Broker, T. R., & Chow, L. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197574 · Cited by 97
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Ren, S., Gaykalova, D. A., Guo, T., Favorov, A. V., Fertig, E. J., Tamayo, P., Callejas-Valera, J. L., Allevato, M., Gilardi, M., Santos, J., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01431-8 · Cited by 93
Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response
Sitz, J., Blanchet, S. A., Gameiro, S. F., Biquand, E., Morgan, T. M., Galloy, M., Dessapt, J., Lavoie, E. G., Blondeau, A., Smith, B. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906102116 · Cited by 77
Self-citationEngineering virus resistance via CRISPR–Cas systems
Mahas, A., & Mahfouz, M. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.06.002 · Cited by 74
BAP31: Physiological functions and roles in disease
Quistgaard, E. M. (2021) · Biochimie · doi:10.1016/j.biochi.2021.04.008 · Cited by 70
Morgan, I., DiNardo, L., & Windle, B. (2017) · Viruses · doi:10.3390/v9080208 · Cited by 65
HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
Ranieri, D., Belleudi, F., Magenta, A., & Torrisi, M. R. (2015) · International Journal of Cancer · doi:10.1002/ijc.29373 · Cited by 54
Belleudi, F., Leone, L., Purpura, V, Cannella, F., Scrofani, C., & Torrisi, M. R. (2011) · Oncogene · doi:10.1038/onc.2011.203 · Cited by 37
Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes
Scott, M. L., Coleman, D. T., Kelly, K. C., Carroll, J. L., Woodby, B., Songock, W. K., Cardelli, J. A., & Bodily, J. M. (2018) · Virology · doi:10.1016/j.virol.2018.03.021 · Cited by 35
Learning from the nexus of autoimmunity and cancer
Mangani, D., Yang, D., & Anderson, A. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.022 · Cited by 33
McLaughlin-Drubin, M., & Munger, K. (2013) · Viruses · doi:10.3390/v5051231 · Cited by 28
Iribarren Díaz, M., Ocampo Hermida, A., González-Carreró Fojón, J., Longueira Suárez, R., Rivera Gallego, A., Casal Núñez, E., Ocampo Álvarez, A., & Cachay, E. (2017) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2017.4274/2016 · Cited by 17
High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation
Chand, V., John, R., Jaiswal, N., Johar, S. S., & Nag, A. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu104 · Cited by 18
Marsh, E. K., Delury, C. P., Davies, N. J., Weston, C. J., Miah, M. A. L., Banks, L., Parish, J. L., Higgs, M. R., & Roberts, S. (2017) · Oncotarget · doi:10.18632/oncotarget.14469 · Cited by 16
Yu, Y., & Munger, K. (2013) · Virology · doi:10.1016/j.virol.2013.08.013 · Cited by 15
Modulating the DNA damage response to improve treatment response in cervical cancer
Cossar, L. H., Schache, A. G., Risk, J. M., Sacco, J. J., Jones, N. J., & Lord, R. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.03.002 · Cited by 12
Pasquier, C., Sauné, K., Raymond, S., Boisneau, J., Courtade, M., & Izopet, J. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.08.022 · Cited by 9
Metadata
- Authors
- Moody, C. A., & Laimins, L. A.
- Venue
- Nature Reviews Cancer
- Published
- 2010-07-01
- Volume
- 10
- Issue
- 8
- Pages
- 550-560
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066332001
- Cited by
- 1,751
- References
- 5
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
